PDF-Fabry Disease Chronic Kidney Disease

IntroductionFabry disease FD arises from an Xlinked defect in lipid storage whereby de31icient or galactosidase A gal A activity leads to systemic deposition of glycosphingolipids mainly. Kevin Harley, M.D.. Assistant Clinical Professor. Department of Medicine. Division of Nephrology & Hypertension. UC Irvine Medical Center. Objectives. Review Definition of CKD and its classification. Epidemiology. CKD affects about 26 million people in the US. Approximately 19 million adults are in the early stages of the disease . On the rise do to increasing prevalence of diabetes and hypertension. Epidemiology. CKD affects about 26 million people in the US. Approximately 19 million adults are in the early stages of the disease . On the rise do to increasing prevalence of diabetes and hypertension. Chronic Kidney Disease: Detection and Management in Primary Care Julia Scialla, MD, MHS, FASN Associate Professor of Medicine and Public Health Sciences University of Virginia Adjunct Associate Professor of Medicine Chronic Kidney Failure Done by : Resources : Objectives : Extra Book Notes Important Golden Notes Differentiate Chronic kidney disease-CKD from Acute Kidney Injury-AKI. Dr. T. A. L. . Dlamini. Specialist Physician and . Nephrologist. Talk overview . Kidney function. Assessing kidney function. Chronic kidney disease (CKD). Benefits of early detection . Conclusion and take home message . Namita Singh, MD, FASN. Year 2021. DISCLOSURES. I have no financial relationships with commercial interests to disclose.. This presentation does not include discussion of off-label or investigational use. . Chronic . c. are . Training . For . district . hospital . Nurses . in . Rwanda . 2013. Session 1: Defining chronic kidney disease. By the end of this Session, participants will be able to:. Screen for chronic kidney disease. Dr. Michael L. West. Division of Nephrology. Department of Medicine. Dalhousie University. Halifax NS. Canada. mlwest@dal.ca. Fabry Disease. . OMIM #301500. Glycosphingolipid= Gb3. Most specific therapies in Fabry disease increase . . Structural . or functional abnormalities of the kidneys for . >. 3 months. . from early to late-stage disease, . Chronic Kidney Disease. as . manifested by either:. 1. Kidney . damage, with or without decreased GFR, as . Quality Department Guidelines for Clinical Care Ambulatory Chronic Kidney Disease Guideline Team Team Leader Jennifer Reilly Lukela, MD General MedicineTeam MembersR. Van Harrison, PhDMedical Educati • What is Fabry Disease?• What Causes Fabry?• How Common is Fabry? Guide to Understanding Fabry Disease mps@mpssociety.or.ukwww.mpssociety.or.uk Dianosis of Fabry DiseaseFabry Dis 2017 . Annual Data Report. Volume 1: Chronic Kidney Disease. 2. vol. 1 Figure 4.1 Prevalence of common cardiovascular diseases in patients with or without CKD, 2015 . Data Source: Special analyses, Medicare 5% sample. Abbreviations: AF, atrial fibrillation; AMI, acute myocardial infarction; CAD, coronary artery disease; CKD, chronic kidney disease; CVA/TIA, cerebrovascular accident/transient ischemic attack; CVD, cardiovascular disease; HF, heart failure; PAD, peripheral arterial disease; SCA/VA, sudden cardiac arrest and ventricular arrhythmias; VHD, . Supported by Sanofi Genzyme. Agenda. Pathogenesis of . Fabry. Disease. Evaluation of . Fabry. Disease. Fabry. Disease Management. Learning Objectives. Discuss the pathophysiology of . Fabry. disease and its impact on kidney function to increase awareness.